CCL2 and breast cancer: In a model of breast cancer, the secretion of IL-1β and TNF-α by transformed cells and immune cells, activates in bone marrow MSCs NF-κB pathway and chemokine secretion like CCL2 and CXCL8/IL-8 that favor an inflammatory TME promoting monocyte migration [26].